Company profile · Turku, Finland

ArcDia International

In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics · Commercial diagnostics platform

Verified 21 Mar 2026 · 3 sources

DiagnosticsCommercial

ArcDia International runs automated ivd platform development, infectious disease diagnostics, and near-patient testing systems in Turku, Finland.

Contact & location
Website
arcdia.com
LinkedIn
Company page
Lead
Janne Koskinen (verified ↗)
Compliance
Not yet on record
Last reviewed
21 Mar 2026 (4mo ago)
Scale
Commercial diagnostics platform
Capabilities
Automated IVD Platform Development · Infectious Disease Diagnostics · Near-Patient Testing Systems
Founded
2002
Headcount
11-50
Editorial note

In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics

ArcDia is published because the official site confirms current leadership, Turku operating footprint, and a real IVD platform centered on automated infectious-disease testing.

Editorial note

ArcDia is published because the official site confirms current leadership, Turku operating footprint, and a real IVD platform centered on automated infectious-disease testing.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 21 March 2026

Verification details

Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Janne Koskinen

CEO and CSO

Check official leadership source
Full addressTykistokatu 4 B, 20520 Turku, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official ArcDia contact page listing the Tykistokatu 4 B Turku address.

Open source
Operating profile

Commercial diagnostics platform

Turku, Finland. In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics. Review completed on 21 Mar 2026.

2026 technical specializationIn-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics
Core capabilities
Automated IVD Platform DevelopmentInfectious Disease DiagnosticsNear-Patient Testing Systems
Governance

Finnish diagnostics and medical-device operating oversight

Official personnel disclosure, Official Turku contact disclosure, Automated IVD platform claim

Capabilities

Automated IVD Platform Development
Infectious Disease Diagnostics
Near-Patient Testing Systems

Sources

The official sources used to verify this profile.

Leadership evidenceOfficial ArcDia personnel material naming Janne Koskinen as CEO and CSO.Source origin: arcdia.comOpen source
Supporting evidenceOfficial ArcDia site describing the mariPOC automated in-vitro diagnostics platform and infectious-disease testing focus.Source origin: arcdia.comOpen source
Physical-site evidenceOfficial ArcDia contact page listing the Tykistokatu 4 B Turku address.Source origin: arcdia.comOpen source

Infrastructure

mariPOC diagnostics platform
Automated infectious-disease testing workflow
IVD development infrastructure

Certifications

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026

Review log

21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.

Frequently asked questions

Where is ArcDia International located?
ArcDia International operates from Tykistokatu 4 B, 20520 Turku, Finland, Turku, Finland.
Who runs ArcDia International?
ArcDia International is led by Janne Koskinen, CEO and CSO. Verified 21 Mar 2026.
What does ArcDia International do?
ArcDia International runs automated ivd platform development, infectious disease diagnostics, and near-patient testing systems in Turku, Finland. Core capabilities: Automated IVD Platform Development, Infectious Disease Diagnostics, Near-Patient Testing Systems.
Editorial context

Related technical briefs

Briefs that name Turku as a covered market or city.